MANILA (Reuters) – Pharmaceutical firm AstraZeneca has applied to health regulators for emergency use authorization (EUA) of its COVID-19 vaccine in the Philppines, the food and drugs agency chief said on Wednesday.
AstraZeneca’s application is the second the Philippine Food and Drug Administration (FDA) has received after Pfizer made a similar application last month.
(Reporting by Neil Jerome Morales; Editing by Andrew Heavens)
Which Mets prospect could get MLB call-up next after Christian Scott’s dazzling debut?
Ohtani hits 11th homer and Buehler returns as Dodgers defeat Marlins 6-3 for 4th straight win
Edwards, Towns lead Wolves’ 106-80 blitz of Murray, Jokic for 2-0 series lead over champion Nuggets
Brunson scores 43, rallies Knicks to 121-117 win over Pacers in Game 1 of Eastern Conference semis
Jalen Brunson becomes fourth NBA player with 4 consecutive 40-point games in the postseason
‘Day of rage’ protest near Met Gala leaves dozens of pro-Palestine marchers arrested
Uproar on the Upper East Side after someone left shirt with swastika at local tailor
Details of UK military personnel exposed in huge payroll data breach
Rescuers contact some workers alive in the rubble of a deadly building collapse in South Africa
The Latest | Israeli military seizes the Gaza side of the Rafah border crossing with Egypt
Minnesota lawmakers debate constitutional amendment to protect abortion and LGBTQ rights
Can yogurt reduce the risk of Type 2 diabetes?
Many Florida women can’t get abortions past 6 weeks. Where else can they go?
With a vest and a voice, helpers escort kids through San Francisco’s broken Tenderloin streets
